Showing results (221-230 of 246) with videos related to

Sort By:
Pageof 25
Journal of the Neurological Sciences|June 14, 2011
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patientsA Kerbrat, E Le Page, E Leray, et al.
Journal of Neuroimmunology|January 8, 2000
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics GroupJ Reboul, C Mertens, F Levillayer, et al.
European Journal of Neurology|February 6, 2013
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosisI Galea, C Lederer, A Neuhaus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcomeM C Etienne, J L Formento, C Lebrun-Frenay, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Journal of Neurology|September 9, 2020
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosisF Lejeune, A Chatton, D-A Laplaud, et al.
Neurology|September 25, 1998
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics GroupC Mertens, D Brassat, J Reboul, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2008
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosisN De Stefano, M Filippi, C Confavreux, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Pageof 25